College of Pharmacy
Most likely, because you are preparing for a career in health care, you have a very high level of compassion, intellectual curiosity, leadership skill and energy for making a difference in the lives of the people you serve. Great, you’re going to fit right in here at Lipscomb! Your educational experience in this college will be characterized by exceptional academics taught by experienced professionals, by Christian faith, and by a very challenging grounding in ethical and compassionate practice. Yes, very lofty and significant goals, but we’re here to walk you through it in a family-like atmosphere where you will be mentored and encouraged to achieve goals you never thought you could.
Lipscomb is the first college of pharmacy in the country to provide student pharmacists a competitive edge in their education through cloud-based access to the IBM Watson Analytics platform. With this tool, students can generate or import data allowing them to explore and discover answers and insights —without relying on outside data scientists or IT. Through this partnership, Lipscomb is helping equip student pharmacists with the skills to help them excel in an evolving health care marketplace.
We train successful pharmacists
How successful you ask? Well take a look at our pass rates for the MPJE and NAPLEX just for starters. A complete list of our quality indicators can be found below.
- 100%Job Placement Rate*
- 95.59%NAPLEX Pass Rate**+
- 80.39%MPJE Pass Rate**+
* Of the pharmacy students who want to be practicing, 100% found jobs and are currently practicing.
** These numbers are based on first-time attempt results for 2016
+ 2016 national average for first-time attempts for NAPLEX was 85.86% and MPJE was 84.74%
College of Pharmacy at-a-glance
Class Facts
- 44% Male
- 56% Female
- 45% Out of State
- 55% In State
- 62% Residency Placement Rate
- 93% On-time Graduation
College Facts
- Founded 2007
- Accredited through 2018
- 8 Residencies available
- 9:1 Students to faculty mentors
- $8 Million research lab
- $1.3 Million in research funding
